- Home
- MSPR vs BME Comparison
MSPR vs BME Comparison
Compare MSPR & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSPR
- BME
- Stock Information
- Founded
- MSPR 2014
- BME 2005
- Country
- MSPR United States
- BME United States
- Employees
- MSPR N/A
- BME N/A
- Industry
- MSPR
- BME Trusts Except Educational Religious and Charitable
- Sector
- MSPR
- BME Finance
- Exchange
- MSPR NYSE
- BME Nasdaq
- Market Cap
- MSPR 7.8M
- BME 462.3M
- IPO Year
- MSPR N/A
- BME N/A
- Fundamental
- Price
- MSPR $0.99
- BME $36.26
- Analyst Decision
- MSPR
- BME
- Analyst Count
- MSPR 0
- BME 0
- Target Price
- MSPR N/A
- BME N/A
- AVG Volume (30 Days)
- MSPR 550.5K
- BME 34.0K
- Earning Date
- MSPR 08-13-2025
- BME 01-01-0001
- Dividend Yield
- MSPR N/A
- BME 6.26%
- EPS Growth
- MSPR N/A
- BME N/A
- EPS
- MSPR N/A
- BME 1.44
- Revenue
- MSPR $13,085,000.00
- BME N/A
- Revenue This Year
- MSPR N/A
- BME N/A
- Revenue Next Year
- MSPR N/A
- BME N/A
- P/E Ratio
- MSPR N/A
- BME $28.37
- Revenue Growth
- MSPR 34.74
- BME N/A
- 52 Week Low
- MSPR $0.91
- BME $35.53
- 52 Week High
- MSPR $13.50
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- MSPR N/A
- BME 50.25
- Support Level
- MSPR N/A
- BME $35.30
- Resistance Level
- MSPR N/A
- BME $37.00
- Average True Range (ATR)
- MSPR 0.00
- BME 0.41
- MACD
- MSPR 0.00
- BME 0.07
- Stochastic Oscillator
- MSPR 0.00
- BME 56.50
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.